田贵华:致力于中医药临床研究规范化与国际化的女郎中

2017-11-13 陈梦瑶 新华网

<p align="center" style="margin: 0px 0px 15px; padding: 0px;"><img id="{42B9F61F-AE37-49EF-BB64-0E89C1EB677A}" title="" border="0" src="https://img.medsci.cn/webeditor/uploadfile/201711/20171113233714900.png" width="764" align="center" height="430" sourcedescription="编辑提供的本地文件" sourcename="本地文件" style="border: 0px solid rgb(0, 0, 0); vertical-align: middle; margin: 10px 0px; max-width: 100%; height: auto !important;"><span style="">北京中医药大学东直门医院推拿疼痛科副主任医师田贵华</span></p><p style="margin: 0px 0px 15

北京中医药大学东直门医院推拿疼痛科副主任医师田贵华

她在临床科研的道路上不忘初心、砥砺前行,脸庞上洋溢着青春的光泽;她矢志不渝、勇于创新,一颗医者的赤诚之心如山溪清泉般清澈见底;她以炽热的爱去拥抱、讴歌和传播中医文化,用心血和汗水浇灌培育中医药临床研究的花朵。她说,科研是临床之翼,临床是科研之根,有了科研的临床,疗效才能如虎添翼、广接地气,并得以持续发展。她,就是北京中医药大学东直门医院推拿疼痛科副主任医师田贵华。

针灸,是传统中医的重要组成部分。作为纯物理疗法,针灸推拿本身具有效优价廉,容易被患者接受的特点,尤其是针灸治疗疼痛,见效快,无毒副作用、无成瘾性和依赖性,已经成为享誉国际的镇痛方法。

虽然针灸微创疗法治疗疼痛效果良好,但因疼痛为患者主观症状,缺乏量化评价方法,再加上受到不同医生的诊断和治疗方案不尽相同的限制,很难建立统一的疗效评价体系。因此,田贵华带领团队着眼于建立中医临床病例报告规范及针灸推拿治疗疼痛的临床评价体系,致力于中医药治疗慢性疼痛的机制研究,做到既可能量化评价,也能够“知其所以然”。

在田贵华看来,由于中西医之间治疗差异较大,只有取长补短、融汇贯通、相互结合,才是未来中西医发展的大趋势。作为新一代中医人,田贵华始终致力于中医药治疗慢性疼痛的临床和机制研究,将循证医学方法运用于中医药临床规范化和标准化的研究,致力于建立中医临床病案报告规范。不但知其然,而且更要知其所以然,于是她便执著不渝地到北大医学部中西医结合学系深造,以致成为联合培养博士,并以优异的成绩递交出了出色答卷。

踏踏实实搞科研、兢兢业业做临床。在收获了病人们叹服点赞的同时,田贵华在中医临床科研方面也颇有成效。在北京中医药大学东直门医院工作期间,她将自己定位为中医临床科研人,不仅在临床疗效上精益求精,在临床科研上更是力求完美和卓越。在临床实践过程中,她看到了目前中医临床存在的诊疗颇欠规范、缺乏统一量化标准等种种问题。于是,她开始寻求破解之道。在一次偶然的学术报告会上,田贵华受到中国循证医学创始人李幼平教授关于中药报告指南论题的启发,会后她欣然决定拜其为师。凭着一股滴水穿石的韧劲,田贵华强练“内功”,终于得到了李幼平教授的特别青睐。在李老师的指导下,正在攻读博士后的田贵华运用循证医学的方法,成功建立了中医临床的标准化和规范化疗效评价体系。

2016年,田贵华主动报名参加中组部第八批援疆干部人才计划。受北京中医药大学委派,她来到新疆医科大学中医学院担任副院长一职。针对新疆中医学院学科弱、底子薄、人才匮乏的现状,田贵华从新疆中医学院的学科建设、人才培养入手,认真制定新疆医科大学“中医药十三五发展规划”,这个规划对该中医学院在十三五期间的发展起到提纲挈领的作用。此外,她经常主动放弃节假日休息,带领中医学院老师加班熬夜完成学科的申报工作。功夫不负有心人。终于,大家的辛劳与付出结出了丰硕果实,中医学科成功申报为新疆维吾尔自治区的高原学科。

作为一名脚踏实地的中医临床科研人,她深知中医要想站在国际舞台上实现创新发展,就必须开展多学科交叉合作,形成以中医药为主线的多学科共同发展模式。打铁更需自身硬。田贵华不仅是中医药临床研究规范化与国际化的先行者,更是践行者。在国家政策的扶持下,她正在积极投身与香港浸会大学、兰州大学、中国科学院、北京市农林科学院开展中医药的规范化与创新型研究。

坐在记者面前的田贵华,侃侃而谈,潇洒而不失严谨,随和而不乏自信。身为一名研究生导师,她时刻告诫学生,医生这个职业一靠医德,二靠医术,全力为病人解除病痛是身为一名医学生所应具备的最基本的素养。既然选择了这个职业,就要把百姓的生命安危放在首位,不得存有半点侥幸和懈怠。屋外秋风萧瑟,晚秋的暖阳缓缓洒入医院的诊室与窗棂。环顾医院内外,环境清洁舒适、绿植茵茵,温馨的氛围给人以回家的亲切感。诊疗室赠送的一面面锦旗释放着关爱的温暖,使人对田贵华的崇敬和信赖之情油然而生。

“科技新星计划培养了一大批青年科学家,为培养各领域国家级的杰出青年甚至是领军人才奠定了基础。正是由于科委给了我科研人生的第一桶金,我才有机会前往多伦多大学做了一年访问学者,成为华西临床医学院的博士后。此外,北京市科委定期组织科技新星交流活动并搭建学术平台,拓展了我的视野,促进了新星之间的多学科交叉。因此,它对我个人成长起到的关键性作用不言而喻。”田贵华如是说。针对中医药类新星人才,田贵华呼吁,增加对中医新星的资助比例,建立中医类评审专家库。其次,由于中医药领域面临着经费不足和人才短缺的问题,加之人才培养的周期较长,因此建立由科委相关部门进行监督的可持续培养的资助机制存在一定的必要性与合理性,希望有关部门出台相关政策给予大力扶持。

与国际相比,目前我国中医临床病例报告规范及相关的中医药治疗疼痛的临床评价体系属于创新型研究,在国际上处于领先水平。对此,田贵华倡议更多的中西医临床专家加入中医临床研究之列,只有中西医并重,才能共谱中医药辉煌发展的新篇章!

相关链接

田贵华,女,中共党员,北京中医药大学与北大医学部联合培养博士,北京中医药大学东直门医院推拿疼痛科副主任医师,硕士生导师。致力于中西医结合临床研究,方向为针药并用治疗慢性疼痛的疗效评价方法及其机制研究。北京中医药大学东直门医院中医内科重点实验室兼职研究员,中组部第八批援疆干部新疆医科大学中医学院副院长。加拿大多伦多大学访问学者,华西医科大学临床医学院博士后。主持国家自然基金课题2项,国家中医药管理局课题1项,北京市科技新星课题1项,省部级课题2项,校级课题1项,参与国家自然基金课题4项。发表学术论文近30篇,其中SCI收录16篇,独立主编出版中医著作6部,获得省部级奖3项,获得发明专利1项。TMR杂志青年编委,JMPR及EBCAM杂志审稿专家。中国中医药信息研究会临床研究分会副秘书长,吴阶平医学基金会营养学部中西医结合营养专业委员会常务理事,中华中医药学会疼痛分会青年委员。
  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-12-19 Homburg
  2. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-15 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-14 Y—xianghai

    学习了新知识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-14 明月清辉

    谢谢分享.学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-14 刘煜

    阅读.谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1915634, encodeId=de131915634d1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Tue Dec 19 21:37:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691356, encodeId=49d71691356c5, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 04 04:37:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409175, encodeId=978d14091e503, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625451, encodeId=e1b61625451c7, content=<a href='/topic/show?id=09a42293e93' target=_blank style='color:#2F92EE;'>#临床研究规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22937, encryptionId=09a42293e93, topicName=临床研究规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Nov 15 14:37:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261200, encodeId=fcd9261200ee, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Nov 14 08:02:21 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261189, encodeId=9d7826118914, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Nov 14 07:38:29 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261160, encodeId=524026116059, content=阅读.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Nov 14 06:54:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261141, encodeId=5c042611419d, content=好好好好好好好好就, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Nov 14 05:08:53 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-14 yjs木玉

    好好好好好好好好就

    0

相关资讯

天冷了,这些水果要“趁热吃”!中医推荐6种吃法

水果营养又美味,但遇上大冷天,就少了很多“追随者”。因为水果多性凉,脾胃虚寒、体质较弱的人在此时享用,不仅不易消化吸收,还有可能引起腹泻。告诉爱吃水果的人一个好消息:不妨把水果做熟了吃,不但寒性会减弱,还能让食疗效果加倍。熟山楂消食山楂中含有大量的有机酸、果酸等,生吃山楂对胃有一定的刺激,以蒸熟为佳。蒸出来的山楂色泽鲜明,酸甜可口,能够健脾开胃,消食化积。做法:将山楂去核,放在碗里,加入冰糖,

中医中药中国行走进福建:唱响八闽中医药好声音

10月26日,“中医中药中国行——福建省中医药健康文化推进行动”暨“晋江市名医工作站”启动仪式在福建省泉州晋江市举行。

“马兜铃酸”之争也是中医药发展契机

▲8种含有马兜铃酸的中草药。图/新京报网相关部门不预设答案,组织和鼓励科学力量进行相应研究,正是最科学的办法。对于中医药而言,这也是最有利的做法。“马兜铃酸”最近成了舆论场上的热词,其导火索系前不久美国的《科学转化医学》(Science Translation Medicine)发表了一篇有关于马兜铃酸与肝癌相关性的文章。文章称,马兜铃酸与亚洲肝癌广泛相关。这让含马兜铃酸的中药,被推上舆论的风口浪

传承弘扬中医是使命

中医、西医是两种不同的知识体系,在防病治病中各有优势,应该优势互补,相互促进,共同完成维护健康、防病治病的历史使命。

民间中医认定开始,赶紧申报!

从《通知》中提到的工作目的和完成要求可以看出,政府对民间中医的重视度极高,这也是一件利国利民的好事。目前正值民间中医填表申报的重要阶段,希望大家都能积极主动起来,相互转告,尤其是山东省的民间中医们,11月底前要填表普查申报了,一定别错过,配合有关部门完成普查工作,为以后光明前途做好铺垫!